What is The BROD GROUP?
The BROD GROUP operates as a premier international consultancy dedicated to the intersection of Health Outcomes, Late Phase research, and Market Access. With a legacy spanning over 35 years, the firm distinguishes itself by maintaining a rigorous patient-centric focus throughout the drug development lifecycle. Their core competencies include the design and execution of Clinical Outcome Assessments and the systematic collection of real-world data. By facilitating qualitative research studies that synthesize insights from patients, clinicians, and caregivers, the company provides essential evidence-based support for late-phase clinical trials. Their reputation is built upon a foundation of high-quality academic output and a comprehensive, logistics-driven approach to complex project management in the life sciences industry.
How much funding has The BROD GROUP raised?
The BROD GROUP has raised a total of $96K across 1 funding round:
Debt
$96K
Debt (2021): $96K with participation from PPP
Key Investors in The BROD GROUP
PPP
Public-Private Partnership
What's next for The BROD GROUP?
With the infusion of $96K, The BROD GROUP is poised to accelerate its strategic initiatives, particularly in the expansion of its real-world evidence capabilities. As the pharmaceutical industry increasingly prioritizes patient-reported outcomes to satisfy regulatory and market access requirements, the firm is expected to scale its research infrastructure and enhance its global footprint. Future growth will likely focus on integrating advanced data analytics into their existing consultancy framework, ensuring that they remain at the forefront of clinical research innovation. This capital deployment will enable the firm to further solidify its market position as a critical partner for biotech entities navigating the complexities of late-stage development and commercialization.
See full The BROD GROUP company page
